Adiponectin isoforms are not associated with the severity of coronary atherosclerosis but with undiagnosed diabetes in patients affected by stable CAD

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 19, Issue 1, 2009, Pages 54-60

  Rizza, Stefano ^a   Clementi, Fabrizio ^a   Porzio, Ottavia ^a,b   Cardellini, Marina ^a   Savo, Alessia ^a   Serino, Matteo ^a   Chiricolo, Gaetano ^b   Romeo, Francesco ^a   Lauro, Renato ^a   Federici, Massimo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Adiponectin; CAD; Diabetes

Indexed keywords

ADIPONECTIN; ISOPROTEIN;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; REGRESSION ANALYSIS;

ADIPONECTIN; AGED; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MIDDLE AGED; PROTEIN ISOFORMS; REGRESSION ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 58149204424     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2007.12.001     Document Type: Article

References (24)

1. Balkau B., Shipley M., Jarrett R.J., Pyorala K., Pyorala M., Forhan A., et al. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men: 20-year follow-up in the Whitehall study, the Paris prospective study, and the Helsinki policemen study. Diabetes Care 21 (1998) 360-373
2. Okamoto Y., Kihara S., Ouchi N., Nishida M., Arita Y., Kumada M., et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106 (2002) 2767-2770
3. Ouchi N., Kihara S., Arita Y., Okamoto Y., Maeda K., Kuriyama H., et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102 (2000) 1296-1301
4. Shibata R., Sato K., Pimentel D.R., Takemura Y., Kihara S., Ohashi K., et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 11 (2005) 1096-1103
5. Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., and Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116 (2006) 1784-1792
6. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., and Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 1291 (2004) 1730-1737
7. Otsuka F., Sugiyama S., Kojima S., Maruyoshi H., Funahashi T., Matsui K., et al. Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease. J Am Coll Cardiol 48 (2006) 1155-1162
8. Frystyk J., Berne C., Berglund L., Jensevik K., Flyvbjerg A., and Zethelius B. Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. J Clin Endocrinol Metab 92 (2007) 571-576
9. Hashimoto N., Kanda J., Nakamura T., Horie A., Kurosawa H., and Hashimoto T. Association of hypoadiponectinemia in men with early onset of coronary heart disease and multiple coronary artery stenoses. Metabolism 55 (2006) 1653-1657
10. Efstathiou S.P., Tsioulos D.I., Tsiakou A.G., Gratsias Y.E., Pefanis A.V., and Mountokalakis T.D. Plasma adiponectin levels and five-year survival after first-ever ischemic stroke. Stroke 36 (2005) 1919-1920
11. Sattar N., Wannamethee G., Sarwar N., Tchernova J., Cherry L., Wallace A.M., et al. Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation 114 (2006) 623-629
12. Kistorp C., Faber J., Galatius S., Gustafsson F., Frystyk J., Flyvbjerg A., et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 112 (2005) 1756-1762
13. Norhammar A., Tenerz A., Nilsson G., Hamsten A., Efendic S., Ryden L., et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359 (2002) 2140-2144
14. Norhammar A., Malmberg K., Diderholm E., Lagerqvist B., Lindahl B., Ryden L., et al. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J Am Coll Cardiol 43 (2004) 585-591
15. Bartnik M., Malmberg K., Norhammar A., Tenerz A., Ohrvik J., and Ryden L. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J 25 (2004) 1990-1997
16. Bartnik M., Ryden L., Ferrari R., Malmberg K., Pyorala K., Simoons M., et al. Euro Heart Survey investigators. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 25 (2004) 1880-1890
17. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85 (2000) 2402-2410
18. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
19. Martuscelli E., Romagnoli A., D'Eliseo A., Tomassini M., Razzini C., Sperandio M., et al. Evaluation of venous and arterial conduit patency by 16-slice spiral computed tomography. Circulation 110 (2004) 3234-3238
20. Nilsson P.M., Engström G., Hedblad B., Frystyk J., Persson M.M., Berglund G., et al. Plasma adiponectin levels in relation to carotid intima media thickness and markers of insulin resistance. Arterioscler Thromb Vasc Biol 26 (2006) 2758-2762
21. Aso Y., Yamamoto R., Wakabayashi S., Uchida T., Takayanagi K., Takebayashi K., et al. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes 55 7 (2006) 1954-1960
22. Ari Arita Y., Kihara S., Ouchi N., Maeda K., Kuriyama H., Okamoto Y., et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 105 (2002) 2893-2898
23. Wang Y., Lam K.S., Xu J.Y., Lu G., Xu L.Y., Cooper G.J., et al. Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem 280 (2005) 18341-18347
24. Shapiro L., and Scherer P.E. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr Biol 8 (1998) 335-338